Anemia

Data from a North American registry show anemia can affect more than 75% of candidates for a left ventricular device implant and up to 67% of recipients in the years after implant, driving higher mortality risk and worse quality of life.

Akebia Therapeutics Inc. has received approval from the European Commission to market its oral hypoxia-inducible factor prolyl hydroxylase inhibitor Vafseo in Europe, according to a press release.

AUSTIN, Texas —An investigational treatment, DISC-0974, can reduce hepcidin and elevate iron levels in healthy patients, according to a presenter at the National Kidney Foundation Spring Clinical Meetings.

AUSTIN, Texas — Patients on dialysis face a host of issues that may lead to long-term depression and jeopardize their chances of getting a transplant, a speaker said here.

AUSTIN, Texas — Patients on dialysis who are hyporesponsive to anemia treatment will likely experience more red blood cell transfusions, according to data presented at the National Kidney Foundation Spring Clinical Meetings.

AUSTIN, Texas —Patients on dialysis who are hyporesponsive to anemia treatment have a higher risk for hospitalizations and death, according to data presented here.

Higher preoperative hemoglobin levels are associated with higher mortality in both men and women after CABG, whereas patients with lower limits of normal hemoglobin levels were at greater risk compared with mid‐normal values, data show.

SCOTTSDALE, Ariz. — Advocacy groups succeeded at placing kidney disease front-and-center on the roadmap to legislative support in Washington, but more improvements are needed, according to presenters at the Southwest Nephrology Conference.

Over time, a declining hemoglobin z score correlates with impaired height among children with mild to moderate nonglomerular chronic kidney disease, according to data published in the American Journal of Kidney Diseases.

Odds of several adverse pregnancy outcomes appeared strikingly similar between pregnant people with anemia and pregnant people with sickle cell disease, according to a study published in JAMA Network Open.